Accurate Measurement of Financial Toxicity Is a Prerequisite to Finding a Remedy

[摘要] Discussions about the affordability of cancer treatments tend to focus on balancing the potential to save and extend lives against the imperative to minimise costs to health care providers [1]. This is for good reasons that are well described in the health economics literature regarding the efficient use of a fixed healthcare budget [2]. Standard guidance on health economic evaluation in most developed nations therefore recommends that only costs incurred by healthcare systems or third-party payers are considered in cost-effectiveness analyses [3]. But it does mean that, to date, less consideration has been given to the broader costs of cancer treatment, including costs borne by individual patients, their family and carers, along with implications to society.

[学科分类] 泌尿医学